DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply

Affiliations

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK. Electronic address: andrea.cipriani@psych.ox.ac.uk.
² Department of Health Promotion and Human Behavior and Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
³ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK.
⁴ Department of Psychiatry and Psychotherapy, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.
⁵ Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece.

Andrea Cipriani et al. Lancet Psychiatry. 2017 Jan.

. 2017 Jan;4(1):22-23.

doi: 10.1016/S2215-0366(16)30415-1.

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK. Electronic address: andrea.cipriani@psych.ox.ac.uk.
² Department of Health Promotion and Human Behavior and Department of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
³ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK.
⁴ Department of Psychiatry and Psychotherapy, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.
⁵ Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece.

No abstract available

Publication types